Compare MPLX LP (MPLX) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Nuvalent Inc — how do they compare? MPLX LP trades at $56.64 (market cap $57.97B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: MPLX LP is far larger — about 5.9× Nuvalent Inc's market cap, and MPLX LP pays a 7.54% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| MPLX | NUVL | |
|---|---|---|
Market Cap | $57.97B | $9.81B |
Sector | Technology | Technology |
52-Week High | $59.17 | $123.96 |
52-Week Low | $47.80 | $72.16 |
Enterprise Value | $82.60B | $8.52B |
Dividend Yield | 7.54% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
